Claude Hamonet

Claude Hamonet

Auto-generated profile, based on publicly available information

Claude Hamonet

Faculté de médecine, université Paris-Est-Créteil, 8, rue du Général-Sarail, 94010 Créteil, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2016 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
JHJustine Hugon-Rodin
Justine Hugon-Rodin
GLGéraldine Lebègue
Géraldine Lebègue
SBStéphanie Becourt
Stéphanie Becourt
CHClaude Hamonet
Claude Hamonet
AGAnne Gompel
Anne Gompel
Hypermobile Ehlers-Danlos syndrome (hEDS), is probably the most common disease among heritable connective tissue disorders. It affects women more than men and causes symptoms in multiple organs. It is associated with chronic pain, skin fragility and abnormal bleeding. These characteristics may hamper reproductive life. We conducted a study to evaluate the gynecologic and obstetric outcomes in women with hEDS. We also explored a possible hormonal modulation of the hEDS symptoms. The gynecologic and obstetric history of 386 consecutive women diagnosed with hEDS was collected by a standardized questionnaire and a medical consultation performed by a senior gynecologist in an expert centre for hEDS between May 2012 and December 2014. We observed a high frequency of gynecologic complaints, specifically: menorrhagia (76 %), dysmenorrhea (72 %) and dyspareunia (43 %). Endometriosis was not highly prevalent in this population. The obstetric outcomes were similar to those of the general French population for deliveries by cesarean section (14.6 %) and premature births (6.2 %) but the incidence of multiple spontaneous abortion (13 %) and spontaneous abortion (28 %) were significantly higher. A subset of women were sensitive to hormonal fluctuations with more severe symptoms occurring during puberty, prior to menstruation, during the postpartum period as well as on oral contraception. Increased awareness of the gynecological symptomatology in women with hEDS can help discriminate between endometriosis and thus prevent useless, and potentially dangerous, surgery. This study also suggests that hormonal modulation may be an appropriate treatment for a subset of women with hEDS.

1 March 2018 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
CBCarolina Baeza-Velasco
Carolina Baeza-Velasco
CBCaroline Bourdon
Caroline Bourdon
LMLucile Montalescot
Lucile Montalescot
CCCécile de Cazotte
Cécile de Cazotte
GPGuillem Pailhez
Guillem Pailhez
CHClaude Hamonet
Claude Hamonet

17 February 2021 in Archives of Suicide Research
Verified
Journal Article
Closed access
CBCarolina Baeza-Velasco
Carolina Baeza-Velasco
CHClaude Hamonet
Claude Hamonet
LMLucile Montalescot
Lucile Montalescot
PCPhilippe Courtet
Philippe Courtet
Hypermobile Ehlers–Danlos syndrome (hEDS) is the most frequent heritable disorder of the connective tissue. This is characterized by a generalized fragility of tissues leading to chronic pain, disa...

13 July 2020 in Children
Verified
Journal Article
Open access
PDF file
VGVincent Guinchat
Vincent Guinchat
EVElodie Vlamynck
Elodie Vlamynck
LDLautaro Diaz
Lautaro Diaz
CCCoralie Chambon
Coralie Chambon
JPJustine Pouzenc
Justine Pouzenc
DCDavid Cohen
David Cohen
(1) Background: Compression garments (CGs) are an adjuvant treatment for generalized joint hypermobility (GJH), including the Ehlers–Danlos syndrome/hypermobility types. The effects of CGs are likely to be related to better proprioceptive control. We aimed to explore the use of CGs in individuals with autism and severe proprioceptive dysfunction (SPD), including individuals with GJH, to control posture and challenging behaviors. (2) Methods: We retrospectively described 14 patients with autism and SPD, including seven with comorbid GJH, who were hospitalized for major challenging behaviors with remaining behavioral symptomatology after the implementation of multidisciplinary approaches, including medication, treatment of organic comorbidities, and behavioral restructuring. Each patient received a CG to wear for at least 1 h (but most often longer) per day for six weeks. We assessed challenging behaviors in these participants with the Aberrant Behavior Checklist (ABC), sensory integration with the Dunn questionnaire, and postural sway and motor performance using a self-designed motricity path at baseline, two weeks, and six weeks. (3) Results: We observed a significant effect on most ABC rating scores at two weeks, which persisted at six weeks (total score, p = 0.004; irritability, p = 0.007; hyperactivity, p = 0.001; lethargy, p = 0.001). Postural control in dorsal and profile positions was significantly improved between before and after wearing the CGs (p = 0.006 and 0.007, respectively). Motor performance was also significantly improved. However, we did not observe a significant change in Dunn sensory scores. During the six-week duration, the treatment was generally well-tolerated. A comorbid GJH diagnosis was not associated with a better outcome. (4) Conclusions: CGs appear to be a promising adjuvant treatment for both behavioral and postural impairments in individuals with autism and SPD.

1 February 2016 in Journal de Réadaptation Médicale : Pratique et Formation en Médecine Physique et de Réadaptation
Verified
Journal Article
Closed access
CHC. Hamonet
C. Hamonet
MVM. Vienne
M. Vienne
CLC. Leroux
C. Leroux
MLM.P. Letinaud
M.P. Letinaud
JPJ. Paumier
J. Paumier
FBF.M. Bird
F.M. Bird

3 December 2011 in La Lettre de Médecine Physique et de Réadaptation
Verified
Journal Article
Closed access
PDF file
CHC. Hamonet
C. Hamonet
GMG. Mazaltarine
G. Mazaltarine
DDD. Deparcy
D. Deparcy